A person cannot take part in the program if they are already receiving GLP-1 medications through their Medicare Part D drug plan to treat type 2 diabetes, moderate to severe sleep apnea, or fatty liver disease
Try feeding promptly after birth
So treat with induction therapy (see figure from Elmasry and Hall CGH 2023) and monitor (nb we do not use sulfasalazine in CD) Escalate if monitoring indicates transition to moderate or severe disease Monitoring of Inflammatory Bowel Disease by Marla Dubinsky #DDW2025 Proactive disease monitoring associated with better outcomes Treat to target strategy should be the gold standard of IBD management IUS-driven treatment optimisation leads the way for treating to target Passive monitoring with wearables and sensors are gaining momentum Tools to monitor for subclinical disease can give way to disease prevention Thanks for following along live from DDW 2025 If youre at the meeting, let me know whats caught your eye on the IBD track
The ratio is stable between pH 6 and 9, but separate calibration curves for every specific pH are recommended as the protonation state of GSH changes
Mechanistically, SELENOP promotes IR by inhibiting the phosphorylation of Acetyl-CoA carboxylase (ACC), a critical enzyme in lipid metabolism
Neuron 63 , 316328 (2009)